Steve Schonfeld’s Precigen PGEN Stock Holding History

Steve Schonfeld’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Sell	21,107 -114,646	-84%	-$496K	﹤0.01%	2277
2026 Q1	$525K	Buy	+135,753	New	+$557K	﹤0.01%	1363
2025 Q4	–	Sell	-856,593	Closed	-$2.82M	–	2465
2025 Q3	$2.82M	Sell	856,593 -581,870	-40%	-$1.64M	0.02%	861
2025 Q2	$2.04M	Sell	1,438,463 -1,355,786	-49%	-$1.93M	0.01%	969
2025 Q1	$4.16M	Buy	+2,794,249	New	+$4.4M	0.03%	590
2022 Q4	–	Sell	-73,800	Closed	-$156K	–	2907
2022 Q3	$156K	Sell	73,800 -61,700	-46%	-$130K	﹤0.01%	2424
2022 Q2	$182K	Sell	135,500 -43,400	-24%	-$64.4K	﹤0.01%	1939
2022 Q1	$377K	Buy	+178,900	New	+$436K	﹤0.01%	1540
2019 Q1	–	Sell	-31,160	Closed	-$204K	–	1188
2018 Q4	$204K	Buy	+31,160	New	+$349K	0.01%	939

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steve Schonfeld's PGEN Position: Q2 2026 in Review

Steve Schonfeld reduced its Precigen (PGEN) stake by 84% in Q2 2026, selling an estimated $496K and leaving 21,107 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Steve Schonfeld first reported a position in PGEN in Q4 2018 and has held it in 9 quarters since. The position peaked at $4.16M in Q1 2025. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Steve Schonfeld held 21,107 shares of Precigen worth $120K as of Q2 2026.
Steve Schonfeld sold 114,646 Precigen shares in Q2 2026, an estimated $496K.
Precigen made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2277 holding.
Steve Schonfeld first reported a position in Precigen in Q4 2018 and has held it in 9 quarters since.
Steve Schonfeld's Precigen position peaked at $4.16M in Q1 2025.
209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.